RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Total assets

VERTEX PHARMACEUTICALS INC【VRTX】

Market cap
$119.1B
P/E ratio
SummaryFinancials
Period EndTotal assets (Million USD)YoY (%)
Dec 31, 202422,533-0.87%
Dec 31, 202322,730+25.23%
Dec 31, 202218,151+35.13%
Dec 31, 202113,433+14.30%
Dec 31, 202011,752+41.27%
Dec 31, 20198,318+33.18%
Dec 31, 20186,246+76.14%
Dec 31, 20173,546+22.41%
Dec 31, 20162,897+15.92%
Dec 31, 20152,499+7.03%
Dec 31, 20142,335+0.67%
Dec 31, 20132,319-15.96%
Dec 31, 20122,759+25.18%
Dec 31, 20112,204+27.75%
Dec 31, 20101,725

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)